Form D Explorer

Form C-AR — Eliaz Therapeutics Inc.

0001872856-26-000133 · filed 2026-04-29

Offering

Target
Maximum
Security type
Price per security
Deadline
Oversubscription

Issuer

CIK
2042609
Entity
Corporation
Jurisdiction
DE
Address
398 TESCONI COURT
SANTA ROSA, CA 95401
Phone

Most recent fiscal year financials

Total assets
$2,589,276
Cash
Short-term debt
$1,796,731
Long-term debt
$8,033,117
Revenues
$332,235
COGS
Taxes paid
Net income
$-1,745,041

Same issuer's Form D filings

View original on SEC EDGAR.